Does tumor location affect renal function after partial nephrectomy?
Mihir M Desai
Correspondence Section of Endourology and Stone Disease, Glickman Urological Institute/A100, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Email desaim1@ccf.org
This article has no abstract so we have provided the first paragraph of the full text.
The past few decades have established nephron-sparing surgery (NSS) as the standard treatment modality for patients with small renal masses. Currently, partial nephrectomy remains the gold-standard NSS option. NSS has become more relevant with the rising incidence of renal cell carcinoma and the increased detection of incidental tumors by abdominal CT or MRI. The current status of partial nephrectomy is the result of several evolutionary stages of NSS, and this evolution is ongoing. The initial step was the transition of partial nephrectomy from a procedure reserved for emergent indications, such as tumor in a solitary kidney or bilateral tumors, to a procedure of choice in patients with a normal contralateral kidney. This step resulted from data that demonstrated oncologic equivalence and a substantial renal function advantage after partial nephrectomy compared with radical nephrectomy.1, 2
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.